Key terms
About ENTX
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ENTX news
Mar 20
8:10am ET
Entera Bio announces PK data from oral GLP-2 peptide tablet treatment
Mar 19
4:55am ET
Entera Bio management to meet virtually with Oppenheimer
Mar 18
4:55am ET
Entera Bio management to meet virtually with Oppenheimer
Mar 13
4:08pm ET
Entera Bio management to meet virtually with Oppenheimer
Mar 12
4:55am ET
Entera Bio management to meet with Oppenheimer
Mar 08
4:23pm ET
Entera Bio Ltd Shares Financial Update for Investor Awareness
Mar 08
4:55am ET
Entera Bio management to meet with Oppenheimer
Mar 05
9:45pm ET
Entera Bio management to meet with Oppenheimer
Mar 05
9:44pm ET
Entera Bio management to meet with Oppenheimer
Mar 04
8:40am ET
Entera Bio regains compliance with Nasdaq minimum bid price requirement
Feb 02
4:19pm ET
Entera Bio files to sell 16.5M ordinary shares for holders
Jan 19
11:24am ET
Biotech Alert: Searches spiking for these stocks today
Jan 18
11:32am ET
Biotech Alert: Searches spiking for these stocks today
Jan 03
8:02am ET
Entera Bio receives extension from Nasdaq to regain compliance
Dec 26
8:07am ET
Entera Bio extends cash runway into 2025
No recent news articles are available for ENTX
No recent press releases are available for ENTX
ENTX Financials
Key terms
Ad Feedback
ENTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ENTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range